Lindsey Hickerson
Family · Munfordville, KYNPI 1376933150
Payments from drug & device makers
Across 278 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Axsome Therapeutics, Inc.$550
- GSK$500
- Pfizer$359
- AstraZeneca$324
- Amgen$286
- plus $1K from 26 others
What the payments were for
- Food & beverage$4,558100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 68 | $1,047 |
| Axsome Therapeutics, Inc. | 27 | $550 |
| GSK | 35 | $500 |
| Pfizer | 25 | $359 |
| AstraZeneca | 15 | $324 |
| Amgen | 17 | $286 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 17 | $249 |
| Lilly USA, LLC | 15 | $239 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $143 |
| Otsuka America Pharmaceutical, Inc. | 7 | $127 |
| Corium, LLC | 6 | $98 |
| Novo Nordisk | 6 | $96 |
| Alkermes, Inc. | 3 | $63 |
| Merck | 2 | $45 |
| Lundbeck LLC | 2 | $41 |
| Biohaven Pharmaceuticals, Inc. | 2 | $39 |
| Exact Sciences | 2 | $38 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Radius Health, Inc. | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $31 |
| Amarin Pharma, Inc. | 2 | $28 |
| Boehringer Ingelheim | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| USWM, LLC | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Kowa Pharmaceuticals America, Inc. | 1 | $17 |
| Sunovion Pharmaceuticals Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $15 |
| Shield Therapeutics Inc | 1 | $15 |
| Medtronic | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Athena Bioscience, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,558 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 46 | $51,992 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 52 | $36,172 |
| VraylarCariprazine Hcl | 22 | $31,586 |
| EliquisApixaban | 21 | $23,910 |
| OzempicSemaglutide | 23 | $23,007 |
| JardianceEmpagliflozin | 23 | $21,552 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 42 | $20,200 |
| FarxigaDapagliflozin Propanediol | 21 | $18,252 |
| XareltoRivaroxaban | 22 | $17,547 |
| JanuviaSitagliptin Phosphate | 13 | $17,115 |
| Tresiba Flextouch U-200Insulin Degludec | 14 | $12,341 |
| LinzessLinaclotide | 16 | $11,372 |
| TradjentaLinagliptin | 15 | $10,860 |
| VascepaIcosapent Ethyl | 23 | $10,838 |
| TrintellixVortioxetine Hydrobromide | 12 | $6,657 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta | $500 | $56,37294 claims |
| Lilly USA, LLCMounjaro | $239 | $51,99246 claims |
| AbbVieVraylar, Linzess | $1,047 | $42,95838 claims |
| Boehringer IngelheimJardiance, Tradjenta, Combivent Respimat | $24 | $37,80149 claims |
| PfizerEliquis, Premarin | $359 | $27,78932 claims |
| Novo NordiskOzempic | $96 | $23,00723 claims |
| AstraZenecaFarxiga | $324 | $18,25221 claims |
| Johnson & JohnsonXarelto | $13 | $17,54722 claims |
| MerckJanuvia | $45 | $17,11513 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $143 | $6,65712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Munfordville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.